Director, Life Sciences Institute, University of Michigan
Co-Founder and CEO, Wetpaint
Founder and CEO of Brooks Bell Inc.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Gaining marketing approval and reimbursement provides market access for your new product, but achieving optimal market access also requires you to negotiate a favorable formulary listing and/or contract for your product. Constructing and negotiating a contract for pricing and utilization of a new product is not an area of expertise for many companies, compared with payers, who are negotiating contracts with hundreds of companies over the course of any given year. Understanding how best to construct and negotiate contracts can mean the difference between a high performing and profitable product, and one that barely makes a return on the significant investment in bringing it to market. More information and online registration about this seminar is here.